Synthetic biology reveals the secrets of life without oxygen

ERC Advanced Grant for natural product researcher Christian Hertweck

15-Jul-2024 - The “AnoxyGen” project will decode novel active substances of anaerobes and elucidate their role in nature. Some of these could be useful for humans, animals and the environment. Christian Hertweck has been awarded one of the ERC Advanced Grants by the European Research Council (ERC). In the ...

British chemist is honoured for her groundbreaking work in mass spectrometry

​​Dame Carol Robinson opened a new era for protein analysis and drug development

27-Jun-2024 - British scientist Dame Carol Robinson, Professor of Chemistry at the University of Oxford and a trailblazer in the field of mass spectrometry, has dedicated her career to exploring the molecular makeup of proteins within their native environments. Her pioneering work has paved the way for ...

Antimicrobial agents of the future

Researchers conducted the first systematic study of CRISPR-based antibiotics in Klebsiella pneumoniae

29-Apr-2024 - The antimicrobial potential of CRISPR-Cas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now addressed this knowledge gap. The ...

NovAliX and Max Planck join forces to advance Cryo-EM driven drug discovery

Collaboration will make vital process of translating scientific research and academic insights into real therapies more efficient and more effective

07-Mar-2024 - NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, announces its long-term strategic partnership with the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen. Through this collaboration, NovAliX and the MPI aim to make the vital process ...

HeartBeat.bio raises € 4.5 million in Pre-Series A financing

New funds to drive development of organoid screening platform for cardiac drug discovery

03-Nov-2023 - HeartBeat.bio AG, a biotech company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease, announced the closing of a € 4.5 million Pre-Series A round co-led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures. The financing ...

NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

25-Mar-2021 - NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. PharmAI announced a partnership with NanoTemper Technologies, the most innovative producer of biophysical characterization devices. Together, ...

Midbrain organoids for automated chemical screening and disease research

Max Planck Innovation licenses process for the generation of organ-like tissue aggregates to biotech company StemoniX

05-Nov-2020 - Sometimes hundreds of thousands of potential therapeutics need to be tested in large-scale, fully automated experiments to identify a single effective drug. Most compounds do not work as desired, and some are even toxic. Since the development of the induced Pluripotent Stem (iPS) Cell technology ...

SMART: Facial recognition for molecular structures

Paradigm shift in interpretation of NMR spectra

09-Nov-2017 - An interdisciplinary team of researchers at the University of California San Diego has developed a method to identify the molecular structures of natural products that is significantly faster and more accurate than existing methods. The method works like facial recognition for molecular ...

Pharmacoscopy: Next-Generation Microscopy

New possibilities for drug discovery

26-Apr-2017 - A novel microscopy method allows unprecedented insights into the spatial organization and direct interactions of immune cells within blood and other liquid multi-lineage tissues. The assay, called “Pharmacoscopy”, developed and patented by scientists from CeMM Research Center for Molecular ...

Alzheimer’s Disease: New Test Identifies the Most Promising Drug Candidates

16-Oct-2015 - Despite enormous efforts of scientists around the world, an effective and causal treatment against Alzheimer’s disease is yet to be found. Many substances that seemed promising initially, later failed in clinical trials, proving ineffective only after years of costly and time consuming tests. ...